Nano-Micro Letters · 2019 · 59 citations · 36 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryCancer NanomedicineMagnetic-responsive Drug DeliveryNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineTumor ImagingAnticancer Drug LoadingDrug Release MechanismsMagnetic Drug Delivery SystemsMagnetic Nanoparticle Drug DeliverySmart Drug Delivery SystemsTheranostic NanomaterialsTumor Microenvironment ResponsivenessTumor-targeted Drug Delivery
Abstract Zeolitic imidazolate frameworks (ZIFs) as smart drug delivery systems with microenvironment-triggered release have attracted much attention for tumor therapy. However, the exploration of ZIFs in biomedicine still encounters many issues, such as inconvenient surface modification, fast drug release during blood circulation, undesired damage to major organs, and severe in vivo toxicity. To address the above issues, we developed an Mn-ZIF-90 nanosystem functionalized with an originally designed active-targeting and pH-responsive magnetic resonance imaging (MRI) Y 1 receptor ligand [Asn 28 , Pro 30 , Trp 32 ]-NPY (25–36) for imaging-guided tumor therapy. After Y 1 receptor ligand modification, the Mn-ZIF-90 nanosystem exhibited high drug loading, better blood circulation stability, and dual breast cancer cell membrane and mitochondria targetability, further favoring specific microenvironment-triggered tumor therapy. Meanwhile, this nanosystem showed promising T 1 -weighted magnetic resonance imaging contrast in vivo in the tumor sites. Especially, this nanosystem with fast clean-up had almost no obvious toxicity and no damage occurred to the major organs in mice. Therefore, this nanosystem shows potential for use in imaging-guided tumor therapy.
36
ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy
Xiaoding Xu, Phei Er Saw, Wei Tao et al. · Advanced Materials · 2017 · 499 citations
Pharmacy, Oncology, Pharmaceutics +17